Abstract
We identified (1) differences in localized prostate cancer (PCa) risk group at presentation and (2) disparities in access to initial treatment for Asian American, Native Hawaiian, and Pacific Islander (AANHPI) men with PCa after controlling for sociodemographic factors.
We assessed all patients in the National Cancer Database with localized PCa with low-, intermediate-, and high-risk disease who identified as Thai, White, Asian Indian, Chinese, Vietnamese, Korean, Japanese, Filipino, Hawaiian, Pacific Islander, Laotian, Pakistani, Kampuchean, and Hmong. Multivariable logistic regression defined adjusted odds ratios (AORs) with 95% CI of (1) presenting at progressively higher risk group and (2) receiving treatment or active surveillance with intermediate- or high-risk disease, adjusting for sociodemographic and clinical factors.
Among 980,889 men (median age 66 years), all AANHPI subgroups with the exception of Thai (AOR = 0.84 [95% CI, 0.58 to 1.21],
> .05), Asian Indian (AOR = 1.12 [95% CI, 1.00 to 1.25],
> .05), and Pakistani (AOR = 1.34 [95% CI, 0.98 to 1.83],
> .05) men had greater odds of presenting at a progressively higher PCa risk group compared with White patients (Chinese AOR = 1.18 [95% CI, 1.11 to 1.25],
< .001; Japanese AOR = 1.36 [95% CI, 1.26 to 1.47],
< .001; Filipino AOR = 1.37 [95% CI, 1.29 to 1.46],
< .001; Korean AOR = 1.32 [95% CI, 1.18 to 1.48],
< .001; Vietnamese AOR = 1.20 [95% CI, 1.07 to 1.35],
= .002; Laotian AOR = 1.60 [95% CI, 1.08 to 2.36],
= .018; Hmong AOR = 4.07 [95% CI, 1.54 to 10.81],
= .005; Kampuchean AOR = 1.55 [95% CI, 1.03 to 2.34],
= .036; Asian Indian or Pakistani AOR = 1.15 [95% CI, 1.07 to 1.24],
< .001; Native Hawaiians AOR = 1.58 [95% CI, 1.38 to 1.80],
< .001; and Pacific Islanders AOR = 1.58 [95% CI, 1.37 to 1.82],
< .001). Additionally, Japanese Americans (AOR = 1.46 [95% CI, 1.09 to 1.97],
= .013) were more likely to receive treatment compared with White patients.
Our findings suggest that there are differences in PCa risk group at presentation by race or ethnicity among Asian American, Native Hawaiian, and Pacific Islander subgroups and that there exist disparities in treatment patterns. Although AANHPI are often studied as a homogenous group, heterogeneity upon subgroup disaggregation underscores the importance of further study to assess and address barriers to PCa care.
